9-month Study to Assess the Efficacy of Ofatumumab on Microglia in Patients With Relapsing Forms of Multiple Sclerosis
Clinical trial NCT04510220 · COMPLETED
Trial details
- NCT number
- NCT04510220
- Sponsor
- Brigham and Women's Hospital
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-21
- Primary completion
- 2022-12-28
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.